Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A4HPG2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.495 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.610 |
DOC_CYCLIN_RxL_1 | 68 | 78 | PF00134 | 0.348 |
DOC_PP2B_LxvP_1 | 57 | 60 | PF13499 | 0.204 |
DOC_PP2B_PxIxI_1 | 59 | 65 | PF00149 | 0.264 |
LIG_14-3-3_CanoR_1 | 118 | 127 | PF00244 | 0.528 |
LIG_BRCT_BRCA1_1 | 88 | 92 | PF00533 | 0.312 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.541 |
LIG_EH1_1 | 6 | 14 | PF00400 | 0.456 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.295 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.569 |
LIG_FHA_2 | 76 | 82 | PF00498 | 0.352 |
LIG_GBD_Chelix_1 | 45 | 53 | PF00786 | 0.367 |
LIG_LIR_Gen_1 | 15 | 25 | PF02991 | 0.567 |
LIG_LIR_Gen_1 | 48 | 58 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 15 | 20 | PF02991 | 0.584 |
LIG_LIR_Nem_3 | 48 | 53 | PF02991 | 0.382 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.367 |
LIG_SH2_CRK | 7 | 11 | PF00017 | 0.469 |
LIG_SH2_CRK | 88 | 92 | PF00017 | 0.359 |
LIG_SH2_STAP1 | 50 | 54 | PF00017 | 0.212 |
LIG_SH2_STAP1 | 7 | 11 | PF00017 | 0.513 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.359 |
LIG_SH2_STAT3 | 116 | 119 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.521 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.560 |
LIG_Sin3_3 | 51 | 58 | PF02671 | 0.234 |
LIG_SUMO_SIM_anti_2 | 8 | 15 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 102 | 107 | PF11976 | 0.328 |
LIG_SUMO_SIM_par_1 | 72 | 78 | PF11976 | 0.357 |
LIG_SUMO_SIM_par_1 | 8 | 15 | PF11976 | 0.496 |
LIG_TYR_ITIM | 86 | 91 | PF00017 | 0.375 |
LIG_WRC_WIRS_1 | 105 | 110 | PF05994 | 0.393 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.385 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.340 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.596 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.323 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.331 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.162 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.343 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.368 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.447 |
MOD_PIKK_1 | 90 | 96 | PF00454 | 0.374 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.258 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.281 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.581 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.345 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.477 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.342 |
TRG_DiLeu_BaEn_1 | 81 | 86 | PF01217 | 0.344 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.553 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.607 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.367 |
TRG_ENDOCYTIC_2 | 7 | 10 | PF00928 | 0.541 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.378 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0Z5 | Leptomonas seymouri | 56% | 100% |
A0A1X0NKL9 | Trypanosomatidae | 42% | 99% |
A0A3Q8IP15 | Leishmania donovani | 80% | 100% |
A0A3R7KH99 | Trypanosoma rangeli | 41% | 100% |
A4ID84 | Leishmania infantum | 80% | 100% |
E9AT74 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q1C3 | Leishmania major | 83% | 100% |